catechin has been researched along with Chronic Kidney Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Du, C; Zhu, J | 1 |
Huang, YW; Pang, QQ; Sheng, J; Wang, XJ; Yang, XY; Yu, CJ; Zhang, XJ; Zhu, QQ | 1 |
Guerrero-Wyss, M; Jara L, L; Montiel P, J; Moris U, G; Mosquera B, M | 1 |
Chen, J; Du, L; Li, J; Song, H | 1 |
Chen, KC; Hsieh, CL; Ker, YB; Peng, CC; Peng, RY; Wang, HY | 1 |
1 review(s) available for catechin and Chronic Kidney Diseases
Article | Year |
---|---|
Could grape-based food supplements prevent the development of chronic kidney disease?
Topics: Antioxidants; Biflavonoids; Catechin; Dietary Supplements; Humans; Oxidative Stress; Proanthocyanidins; Renal Insufficiency, Chronic; Vitis | 2020 |
4 other study(ies) available for catechin and Chronic Kidney Diseases
Article | Year |
---|---|
EGCG targeting Notch to attenuate renal fibrosis
Topics: Animals; Antioxidants; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Injections, Intraperitoneal; Mice; Mice, Inbred ICR; Random Allocation; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Streptozocin; Transforming Growth Factor beta | 2020 |
[CHRONIC KIDNEY DISEASE AND ITS RELATIONSHIP WITH INTAKE OF TURMERIC, CATECHINS, PROANTHOCYANIDINS AND OMEGA-3].
Topics: Adult; Aged; Aged, 80 and over; Animals; Catechin; Curcuma; Fatty Acids, Omega-3; Feeding Behavior; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proanthocyanidins; Rats; Renal Dialysis; Renal Insufficiency, Chronic | 2015 |
Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis.
Topics: Animals; Antioxidants; Blotting, Western; Cadmium; Catechin; Fibrosis; Immunoenzyme Techniques; Male; Oxidative Stress; Rats; Rats, Wistar; Renal Insufficiency, Chronic | 2016 |
Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease.
Topics: Albuminuria; Animals; bcl-2-Associated X Protein; bcl-Associated Death Protein; Blood Urea Nitrogen; Caspase 3; Catechin; Cholesterol; Creatinine; Dietary Supplements; Doxorubicin; Flavanones; Glomerular Filtration Rate; In Situ Nick-End Labeling; Insulin; Kidney; Male; Malondialdehyde; Oxidative Stress; PPAR alpha; Quercetin; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Rutin; Superoxide Dismutase; Triglycerides; Uric Acid | 2012 |